News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenues declining sharply but significant clinical milestones achieved. The company continues to face cash burn risks while ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results